To: All persons and/or entities who purchased common stock in the United States or on the NASDAQ Stock Market in Chelsea Therapeutics International, Ltd. [CHTP] during the period from September 20, 2010 through May 21, 2012, both date inclusive, and were damaged thereby; a settlement has been announced in the securities litigation known as Cameron McIntyre v. Chelsea Therapeutics, International, Ltd., et al. Civil Action No. 3:12-cv-213-MOC-DCK, United States District Court for the Western District of North Carolina. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below):
Claim submission deadline is September 4, 2016.
If you have any questions about the settlement, please contact the Claims Administrator. Their contact information can be found in the attached Notice.
Contact Us for
10205 North Pennsylvania Avenue, Oklahoma City, Oklahoma 73120Ph: 405.235.1560 Fax: 405.239.2112
Copyright © 2017 Federman & Sherwood. All Rights Reserved.